Cargando…
Lack of Evidence for Blood Pressure Effects of Caffeine Added to Ibuprofen
BACKGROUND: Caffeine enhances the efficacy of non-opioid analgesics. Data on the cardiovascular health effects of caffeine intake are controversial, and studies on the cardiovascular effects of medical caffeine use are lacking. OBJECTIVE: The study aims to explore the cardiovascular effects of an ib...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173466/ https://www.ncbi.nlm.nih.gov/pubmed/35430997 http://dx.doi.org/10.2174/1574886317666220414125027 |
_version_ | 1785039823895003136 |
---|---|
author | Lampert, Anette Lange, Robert Weiser, Thomas |
author_facet | Lampert, Anette Lange, Robert Weiser, Thomas |
author_sort | Lampert, Anette |
collection | PubMed |
description | BACKGROUND: Caffeine enhances the efficacy of non-opioid analgesics. Data on the cardiovascular health effects of caffeine intake are controversial, and studies on the cardiovascular effects of medical caffeine use are lacking. OBJECTIVE: The study aims to explore the cardiovascular effects of an ibuprofen/caffeine combination in comparison to ibuprofen alone. METHODS: Secondary analysis of a previously reported bioequivalence study of a single dose of a fixed dose ibuprofen/caffeine combination (400/100 mg) vs. ibuprofen alone in a randomized, cross-over design in 36 healthy volunteers. Plasma catecholamines were analyzed to enhance mechanistic interpretation of the data. RESULTS: After exclusion of 10 protocol violators (pre-dosing intake of caffeine), vital signs were comparable over a 24-h period in the absence and presence of caffeine. Plasma catecholamine levels were also comparable. CONCLUSION: These data do not support the hypothesis that occasional intake of a small dose of caffeine as part of pain medication imposes a health risk due to vital sign changes. Based on the proven increase in efficacy, the addition of caffeine to non-opioid analgesics such as IBU has a favorable risk/benefit profile for occasional use. |
format | Online Article Text |
id | pubmed-10173466 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Bentham Science Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-101734662023-05-12 Lack of Evidence for Blood Pressure Effects of Caffeine Added to Ibuprofen Lampert, Anette Lange, Robert Weiser, Thomas Curr Drug Saf Drug Design, Discovery and Therapy, Drug Design & Discovery, Pharmacology BACKGROUND: Caffeine enhances the efficacy of non-opioid analgesics. Data on the cardiovascular health effects of caffeine intake are controversial, and studies on the cardiovascular effects of medical caffeine use are lacking. OBJECTIVE: The study aims to explore the cardiovascular effects of an ibuprofen/caffeine combination in comparison to ibuprofen alone. METHODS: Secondary analysis of a previously reported bioequivalence study of a single dose of a fixed dose ibuprofen/caffeine combination (400/100 mg) vs. ibuprofen alone in a randomized, cross-over design in 36 healthy volunteers. Plasma catecholamines were analyzed to enhance mechanistic interpretation of the data. RESULTS: After exclusion of 10 protocol violators (pre-dosing intake of caffeine), vital signs were comparable over a 24-h period in the absence and presence of caffeine. Plasma catecholamine levels were also comparable. CONCLUSION: These data do not support the hypothesis that occasional intake of a small dose of caffeine as part of pain medication imposes a health risk due to vital sign changes. Based on the proven increase in efficacy, the addition of caffeine to non-opioid analgesics such as IBU has a favorable risk/benefit profile for occasional use. Bentham Science Publishers 2023-01-01 2023-01-01 /pmc/articles/PMC10173466/ /pubmed/35430997 http://dx.doi.org/10.2174/1574886317666220414125027 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode |
spellingShingle | Drug Design, Discovery and Therapy, Drug Design & Discovery, Pharmacology Lampert, Anette Lange, Robert Weiser, Thomas Lack of Evidence for Blood Pressure Effects of Caffeine Added to Ibuprofen |
title | Lack of Evidence for Blood Pressure Effects of Caffeine Added to Ibuprofen |
title_full | Lack of Evidence for Blood Pressure Effects of Caffeine Added to Ibuprofen |
title_fullStr | Lack of Evidence for Blood Pressure Effects of Caffeine Added to Ibuprofen |
title_full_unstemmed | Lack of Evidence for Blood Pressure Effects of Caffeine Added to Ibuprofen |
title_short | Lack of Evidence for Blood Pressure Effects of Caffeine Added to Ibuprofen |
title_sort | lack of evidence for blood pressure effects of caffeine added to ibuprofen |
topic | Drug Design, Discovery and Therapy, Drug Design & Discovery, Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173466/ https://www.ncbi.nlm.nih.gov/pubmed/35430997 http://dx.doi.org/10.2174/1574886317666220414125027 |
work_keys_str_mv | AT lampertanette lackofevidenceforbloodpressureeffectsofcaffeineaddedtoibuprofen AT langerobert lackofevidenceforbloodpressureeffectsofcaffeineaddedtoibuprofen AT weiserthomas lackofevidenceforbloodpressureeffectsofcaffeineaddedtoibuprofen |